Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,741 JPY | -3.96% | +1.18% | 0.00% |
10:58am | Calliditas Therapeutics' Potential Head and Neck Cancer Treatment Meets Secondary Endpoints | MT |
07:46am | UK Tribunal Greenlights GBP790 Million Lawsuit vs Prysmian, Nexans, NKT | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
0.00% | 2.12B | |
+14.09% | 330B | |
-10.10% | 65.97B | |
-0.55% | 30.2B | |
+22.93% | 23.68B | |
+9.66% | 14.4B | |
+14.15% | 9.84B | |
+23.15% | 9.55B | |
-6.89% | 6.56B | |
+4.53% | 4.71B |
- Stock Market
- Equities
- 141A Stock
- News Trial Holdings Inc.
- Marinus Pharmaceuticals Shares Fall After Phase 3 Trial Interim Analysis of Ganaxolone